For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...
May 25, 2022
0
11
Southampton researchers have demonstrated a quick and accurate method to diagnose bacterial infections. The technique has the potential to detect infections in cystic fibrosis patients in minutes rather than days.
Apr 29, 2022
0
4
An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers.
Apr 7, 2022
0
23
Ulcerative colitis (UC) is a nonspecific, chronic and recurrent inflammatory bowel disease. Alpinia plants (Zingiberaceae family) are the ideal materials for finding therapeutic agents against UC. Alpinia hainanensis is an ...
Mar 31, 2022
0
3
University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing "superbugs" including MRSA without detectable resistance.
Mar 29, 2022
0
451
Researchers at Murdoch University's Australian National Phenome Centre have discovered a new set of biomarkers for increased risk of cardiovascular disease in patients with COVID-19 infections.
Mar 3, 2022
0
15
The Src protein takes part in the regulation of many physiological processes such as the survival, migration or cell adhesion as a response to stimuli received from several receptors of the membrane. Although it is demonstrated ...
Jan 12, 2022
0
1
A new study led by University of California, Irvine researchers has confirmed a link between altered DNA repair and increased DNA damage associated with spinocerebellar ataxia type 7 (SCA7), a debilitating, sometimes deadly ...
Nov 30, 2021
0
26
Human Usher syndrome (USH) is the most common form of hereditary deaf-blindness. Sufferers can be deaf from birth, suffer from balance disorders, and eventually lose their eyesight as the disease progresses. For some 25 years ...
Jul 12, 2021
0
2
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease. This is stated in the recent studies by the Research Group ...
Jun 29, 2021
0
2
